Citius Oncology Inc.CTORNASDAQ
Loading
Stockholders Equity Over TimeStable
Percentile Rank67
3Y CAGR+7.3%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
+7.3%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
2025$44.87M-2.8%
2024$46.14M+80.7%
2023$25.54M-29.6%
2022$36.27M-